Tower Research Capital »

Verve Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $28k 2.1k 13.26
2023-06-30 $67k 3.5k 18.75
2023-03-31 $91k 6.3k 14.37
2022-12-31 $116k 6.0k 19.44
2022-09-30 $246k 6.1k 40.00
2022-06-30 $32k 2.3k 13.89
2022-03-31 $88k 3.8k 23.08
2021-12-31 $217k 5.8k 37.14
2021-09-30 $52k 1.1k 47.56